covid
Buscar en
Revista Colombiana de Anestesiología
Toda la web
Inicio Revista Colombiana de Anestesiología Tromboembolísmo venoso postoperatorio: grave riesgo prevenible
Journal Information
Vol. 38. Issue 4.
Pages 499-507 (November - January 2011)
Share
Share
Download PDF
More article options
Vol. 38. Issue 4.
Pages 499-507 (November - January 2011)
ARTÍCULOS DE REFLEXIÓN
Open Access
Tromboembolísmo venoso postoperatorio: grave riesgo prevenible
Postoperatory Venous Thromboembolism
Visits
3487
A. Wilson Valencia
, Johnnie Smith Husbands Luque**
* Médico Anestesiólogo Universidad del Valle. Profesor Facultad de Medicina Universidad Santiago de Cali. Anestesiólogo Hospital San Juan de Dios, Cali, Colombia.
** Médico Anestesiólogo Universidad Nacional de Colombia. Profesor Facultad de Medicina Universidad Libre Seccional Cali. Instructor Reanimación AHA BLS ACLS Fundación Reanimación Colombia – SCARE. Anestesiólogo Clínica Nuestra Señora de los Remedios, Clínica Rafael Uribe Uribe, Cali, Colombia.
This item has received

Under a Creative Commons license
Article information
RESUMEN

La trombosis venosa profunda y el tromboembolísmo pulmonar postoperatorio son complicaciones que tienen influencia en la morbimortalidad. Múltiples investigaciones evidencian sus cifras y la reducción del riesgo con la tromboprofilaxis. Han sido evaluados diferentes medicamentos y su nivel de protección, pero el seguimiento de las guías de práctica clínica publicadas no es óptimo debido a la falta de claridad en el manejo de pacientes con factores de riesgo intermedio. La prevención demostrada por la tromboprofilaxis obliga a implementar estrategias para detectar pacientes en riesgo y seguir las guías.

Palabras clave:
Trombosis
embolismo
riesgo profilaxis. (Fuente: DeCS, BIREME)
SUMMARY

Postoperative deep venous thrombosis and pulmonary thromboembolism are complications which have incidence on morbimortality. Many researches evidence their figures and how thromboprophylaxis can reduce these risks. Different drugs and their level of protection have been evaluated, but the adherence to the published clinical practice guidelines is not optimal because of the lack of clarity in the management of patients with intermediate risk factors. The proved prevention with thromboprophylaxis forces to implement strategies to detect the patients at risk and to follow the guidelines.

Keywords:
Thrombosis
embolism
risk
prophylaxis. (Source: MeSH, NLM)
Full text is only aviable in PDF
REFERENCES
[1.]
W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama.
Prevention of Venous Thromboembolism. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Eight Edition. CHEST, 133 (2008), pp. 381S-453S
[2.]
A.K. Kakkar, A.T. Cohen, V.F. Tapson, J.F. Bergmann, S.Z. Goldhaber, B. Deslandes.
Venous Thromboembolism Risk and Prophylaxis in the Acute Care Hospital Setting.
Ann Surg, (2010), pp. 330-338
[3.]
S. Motte, C.M. Samama, J. Guay, J. Barre, J.Y. Borg.
Prevention of Postoperative Venous Thromboembolism. Risk Assessment and Methods of Prophylaxis.
Can J Anesth, (2006), pp. S68-S79
[4.]
S. Sweetland, J. Green, B. Liu, A. Berrington, M. Canonico, G. Reeves.
Duration and Magnitude of The Postoperative Risk of Venous Thromboembolism in Middle Aged Women: Prospective Cohort Study.
[5.]
F.A. Michota.
Prevention of Venous Thromboembolism after Surgery.
Clev Clin J Med, 76 (2009), pp. S45-S52
[6.]
C. Mantilla, T.T. Horlocker, D.R. Schroeder, D.J. Berry.
Risk Factors for Clinically Relevant Pulmonary Embolism and Deep Venous Thrombosis in Patients Undergoing Primary Hip or Knee Arthroplasty.
Anesthesiology, (2003), pp. 552-560
[7.]
A.G. Turpie, M.R. Lassen, B.L. Davidson.
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty: a Randomised Trial.
Lancet, (2009), pp. 1673-1680
[8.]
B.I. Eriksson, L.C. Borris, R.J. Friedman.
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty.
N Engl J Med, (2008), pp. 2765-2775
[9.]
M. Lumpkin.
FDA Public Health Advisory.
Anesthesiology, (1998), pp. 27A-28A
[10.]
J.W. Eikelboom, D.J. Quinlan, J.D. Douketis.
Extended Duration Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement: a Meta-Analysis of the Randomized Trials.
[11.]
D. Bergqvist, G. Agnelli, A.T. Cohen.
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer.
N Engl J Med, (2002), pp. 975-980
[12.]
N. Strebel, M. Prins, G. Agnelli, H.R. Büller.
Preoperativeor Postoperative Start of Prophylaxis for Venous Thromboembolismwith Low-Molecular-Weight Heparin Inelective Hip Surgery?.
Arch Intern Med, 162 (2002), pp. 1451-1456
[13.]
American Academy of Orthopedic Surgeons.
Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism in Patients undergoing Total Hip or Knee Arthroplasty.
Copyright © 2010. Revista Colombiana de Anestesiología
Article options